References

1. Crooks PA, Damani LA. Drug application to the respiratory tract: metabolic and pharmacokinetic considerations. In: Byron PR, ed. Respiratory Drug Delivery. Boca Raton, FL: CRC Press, 1989:61.

2. Brown DT, Marriott C, Beeson MF. J Pharm Pharmacol 1983; 35(suppl):83P.

4. Patton JS, Platz RM. Adv Drug Deliv Rev 1992; 8:179.

5. Colthorpe PF, Smith SJ, Wyatt IJ, Taylor D. Pharm Res 1995; 12:356.

6. Possmayer F, Yu S, Weber JM, Harding PGR. Can J Cell Biol 1984; 62:1121.

7. Boucher RC. Human airway ion transport—part one. Am J Respir Crit Care 1994; 150:271.

8. Patton JS. Mechanism of macromolecule absorption by the lung. Adv Drug Deliv 1996; 19:3.

9. Schanker LS. Biochem Pharmacol 1978; 27:381.

10. Schanker LS, Mitchell EW, Brown RA. Drug Metab Dispos 1986; 4:79.

11. Adamson RH, Liu B, Fry GN, Rubin LL, Curry FE. Microvascular permeability and number of tight junctions are modulated by cAMP. Am J Physiol 1998; 274:H1885.

12. Walter U, Geiger J, Haffner C, Market T, Nehls C, Silber RE, Schanzenbacher P. Platelet-vessel wall interactions, focal adhesions, and the mechanism of action of endothelial factors. Agents Action 1995; 45(suppl):255.

13. Taylor A, Khimenko P, Moore T, Adkins W. Fluid Balance. Philadelphia: Lippincott-Raven, 1997.

14. Chetham PM, Babal P, Bridges J, Moore T, Stevens T. Segmental regulation of pulmonary vascular permeability by store operated Ca2+ entry. Am J Physiol 1999; 276:L41.

15. Townsley M, Parker J, Longenecker G, Perry M, Pitt R, Taylor A. Pulmonary embolism: analysis of endothelial pore sizes in canine lung. Am J Physiol 1988; 255:H1075.

16. Moore T, Chetham PM, Kelly JJ, Stevens T. Signal transduction and regulation of lung endothelial cell permeability: interaction between calcium and camp. Am J Physiol 1998; 275:L203.

17. Del Vecchio P, Siflinger-Birnboim A, Belloni PN, Holleran LA, Lum H, Malik AB. Culture and characterization of pulmonary microvascular endothelial cells. In Vitro Cell Dev Biol 1992; 28A:711.

18. Schaeffer R Jr, Bitrick M Jr. Effects of human a-thrombin and 8-bromo-cAMP on large and microvessel endothelial monolayer equivalent "pore" radii. Microvasc Res 1995; 49:364.

19. Schnitzer J, Siflinger-Birnboim A, Del Vecchio PJ, Malik AB. Segmental differentiation of permeability, protein glycosylation, and morphology of cultured bovine lung vascular endothelium. Biochem Biophys Res Commun 1994; 199:11.

20. Seibert AF, Thompson WJ, Taylor A, Wilborn WH, Bernard J, Haynes J. Reversal of increased microvascular permeability associated with ischemia-reperfusion: role of cAMP. J Appl Physiol 1992; 72:389.

Stevens T, Creighton J, Thompson J. Control of cAMP in lung endothelial cell phenotype. Implications for control of barrier function. Am J Physiol 1999; 277:L119.

Wangensteen D. Microstructural aspects of macromolecular transport across pulmonary epithelia. In: Proceedings of the Second International Symposium on Respiratory Drug Delivery (in press).

Burton PS. The influence of peptide structure on transport across epithelial cells. In: Proceedings of the Second International Symposium on Respiratory Drug Delivery (in press).

Schnee EE, Lynch RD. Am J Physiol 1992; 262:L647. Vaccaro CA, Brody JS. J Cell Biol 1981; 91:427. Sun, JZ, Byron PR, RypacekF. Pharm Res 1999; 16(7):1104. Niven RW, Rypacek F, Byron PR. Pharm Res 1990; 7:990. Benford DJ, Bridges JW. Prog Drug Metab 1986; 9:53.

Sabourin PJ, Dahl AR. Distribution of the FAD-containing monooxygenase in respiratory tract tissues. Annual Report LMF-114. In: Medinsky MA, Muggenburg BA, eds. National Technical Information Service. Springfield, VA, 1985:156.

Gonda I, Harpur ES. Metabolism of hexamethylmelamine by rodent lung microsomes. In: Proceedings of 10th International Congress of Pharmacology (IUPHAR), 1987; 1045.

Sly RM. J Allergy Clin Immunol 1989; 84:421; Buiet AS. J Allergy Clin Immunol 1989; 84:275.

Lenny W, Wells N, O'Neal BA. Eur Respir Rev 1994; 4:49.

Barnes NC. J Pharm Pharmacol 1997; 49:13.

Chhabra SK, Bhatnager S. Indian J Chest Allied Sci 2002; 44(2):91.

Lands AM, Ludena FP, Buzzo HJ. Life Sci 1967; 6:2241; Collier JG, Dornhurst

AC. Nature 1969; 223:1283.

Iversen LL. Br J Pharmacol 1971; 41:571.

Carstairs JR, Nimmo AJ, Barnes PJ. Am Rev Respir Dis 1985; 132:541. Ullman A, SvedmyrN. Thorax 1988; 43:674.

Bradshaw J, Brittain RT, Coleman RA, Jack D, Kennedy I, Lunts LHC, Skidmore IF. Br J Pharmacol 1987; 92:590.

Ullman A, Svedmyr N. Am Rev Respir Dis 1988; 137(suppl):32A. Lofdahl CG, Svedmyr N. Am Rev Respir Dis 1988; 137(suppl):330A. Barnes PJ. Eur Respir J 2002; 19(1):182.

Chiarino D, Fantucci M, Della Bella D, Frigeni V, Sala R. Farmaco Ed Sci 1986; 41:4401.

Minneman KP, Hegstrand LR, Molinoff PB. Mol Pharmacol 1979; 16:21; Minneman KP, Hedberg KP, Molinoff PB. J Pharm Exp 1979; 211:502. Rugg EL, Barnett DB, Nahorski SR. Mol Pharmacol 1978; 14:996. Levy GP, Apperley GH. In: Szabadi E, Bradshaw CM, Bevan P, eds. Recent Advances in the Pharmacology of Adrenoceptors. Amsterdam: Elsevier/North Holland, 1978:201.

Gibson DJ, Coltart DJ. Postgrad Med J 1971; 45(S):40.

Ryan G, Dolovich MB, Obminski G, Cockcroft DW, Juniper E, Hargreave FE,

Newhouse MT. J Allergy Clin Immunol 1981; 67:156.

Shaw A. Annu Rep Med Chem 1989; 25:61.

Cheng HC, Woodward JK. Drug Dev Res 1982; 2:11.

Villani FJ, Magatti CV, Vashi DB, Wong J, Popper TL. Arzneim Forschd/Drug Res 1986; 36:1311.

Ahn HS, Barnett A. Eur J Pharmacol 1986; 127:153.

Brown EA, Griffiths R, Harvey CA, Owen DAA. Rev J Pharmacol 1986; 87:569. Nicholson AN, Stone BM. Br J Clin Pharmacol 1995; 19:127P. deVos C, Rihoux JP, Juhlin L. In: Proceedings of the Congress of the European Academy of Allergology and Clinical Immunology. Budapest, 1986. Stokbroekx RA, Luyckx MGM, Willems JJM, Janssen M, Bracke JOMM, Joosen RLP, Van Wauwe IP. Drug Dev Res 1986; 8:87.

Fugner A, Bechtel WD, Kuhn FJ, Mierau J. Arzneim-Forschd/Drug Res 1988; 32:1445.

Nolan JC, Stephens DJ, Proakis AG, Leonard CA, Johnson DN, Kilpatrick BF, Foxwell MH, Yanni JJ. Agents Actions 1989; 28:53.

Palmer GC, Radov LA, Napier JJ, Griffiths RC, Stagnitto ML, Garske GE. FASEB J 1989; 3:A639.

Vincent J, Liminana R, Meredith PA, Reid JL. Br J Clin Pharmacol 1988; 26:497. Vincent J, Summer DJ, Reid JL. Br J Clin Pharmacol 1988; 26:503. Zaagsma J, Roffel AF, Meurs H. Life Sci 1997; 60:1061.

Buckle DR, Smith H. Development of Anti-asthma Drugs. London: Butterworths, 1984:159-183.

Rominger KL. Chemistry and pharmacokinetics of ipratropium bromide. Scand J RespirDis 1978; 103(suppl):116-129.

Frith PA, Ruffin RE, Cockcroft DW, Hargreave FE. J Allergy Clin Immunol 1978; 61:175.

Storms WW, DePico OA, Reed CE. Am Rev Respir Dis 1975; 111:419.

Schlueter DP, Neuman JL. Chest 1978; 73(suppl):982.

Tamoaki J, Chiyotani A, Tagaya E, Sakai N, Konno K. Thorax 1994; 49:545.

Alabaster VA. Life Sci 1997; 60:1053.

Kelly HW. J Allergy Clin Immunol 1998; 102:S36.

Pedersen S, O'Byrne P. Allergy 1997; 52:1.

Allen DB. Acta Paediatr 1998; 87(2):123.

Bernstein DI, Berkowitz RB, Chervinsky P, Dvorin DJ, Finn AF, Gross GN, Karetsky M, Kerap JP, Laforce C, Lumry W, Mendelson LM, Nelson H, Pearlman D, Rachelefsky G, Ratner P, Repsher L, Segal AT, Selner JC, Settipare GA, Wanderer A, Guss FM, Nolop KB, Harrison JE. Respir Med 1999; 93:603. Barnes PJ, Pedersen S, Busse WW. Am J Respir Crit Care Med 1998; 157:S1. Onrust SV, Lamb HM. Drugs 1998; 56(4):725.

Petersen H, Kullberg A, Edsbacker S, Greiff L. Br J Clin Pharmacol 2001; 51(2):159.

Miller-Larson A, Mattsson H, Hjertberg E, Dahlback M, Tunek A, Brattsand R. Drug Metab Dispos 1998; 26(7):623.

78. Sorkness CA. J Allergy Clin Immunol 1998; 102:S52.

79. Petersen H, Kulbery A, Edsbacker S, Creiff L. Br J Clin Pharm 2001; 51(2):159.

80. Van Grunsen PM, Van Schaych CP, Derenne JP, Kerstjens HA, Renkema TE, Postma DS, Similowski T, Akkermans RP, Pasker PC, Jong D, Dekhuijzen PN, Van Herwaarden CL, Van Weel C. Thorax 1999; 54:7.

81. Douglas WP, Barnette HS, Barnette MS. Annu Rep Med Chem 1999; 34(11):111.

82. Lacoste JY, Bousquet J, Chanez P, et al. J Allergy Clin Immunol 1993; 92:537.

83. Ziment I. Clin Chest Med 1990; 11:461.

84. Van Schaych CP, Van Grunsven PM, Dekhuijzen PNR. Eur Respir J 1996; 9:1969.

85. Wilson JD, Serby CW, Menjoge SS, Witek TJ Jr. Eur Respir J 1996; 6:286.

86. Barnes PJ. J Allergy Clin Immunol 1996; 97:159.

87. Britton JR, Hanley SP, Tattersfield AE. J Allergy Clin Immunol 1987; 79:811; Fleisch JH, Cloud ML, Marshall WS. Ann NY Acad Sci 1988; 524:356; Barnes N, Evans J, Zakrzewski J, Piper P, Costello J. Ann NY Acad Sci 1988; 524:369.

88. Smith L, Geller S, Ebright, L, Glass M, Thyrum PT. Am Rev Respir Dis 1990; 141(4):988.

89. Krell RD, Buckner CK, Keith RA, Snyder DW, Brown FJ, Bernstein PR, Matussa V, Yee YK, Hesp B, Giles RE. J Allergy Clin Immunol 1988; 81:276.

90. Jones TR, Zamboni R, Belley M, Champion E, Charette L, Ford-Hutchinson AW, Frenette R, Gauthier J-Y, Leger S, Masson P, McFarlane CS, Piechuta H, Rokach J, Williams H, Young RN, Dehaven R, Pong SS. Can J Physiol Pharmacol 1989; 67:17.

91. Depre M, Margolskee DJ, Van Hecken A, Hsieh JSY, Buntinx A, De Schepper PJ, Rogers JD. Eur J Clin Pharmacol 1992; 43(4):431.

92. Jacob RT, Veale CA, Wolanin DJ. Annu Rep Med Chem 1992; 27(12):109.

93. Joos GF, Kips JC, Puttemans M, Pauwels RA, Van Der Straeten ME. J Allergy Clin Immunol 1989; 83:187.

94. Creticos PS, Bodenheimer S, Albright A, Lichtenstein LM, Norman PB. J Allergy Clin Immunol 1989; 83:187.

95. Evans JM, Barnes NC, Zakzewski JT, Sciberras DG, Stahl EG, Piper J, Costello JF. Br J Clin Pharmacol 1989; 28:125.

96. Brooks DM, Summers JB, Gunn BP, Martin JC, Martin MB, Mazdiyasni H, Holms JH, Stewart AO, Moore JL, Young PR, Albert DH, Bouska JB, Dyer RD, Bell RL, Carter GW. 197th ACS Annual Meeting (abstr) (MEDI 69 1989).

97. Bruneau BJ, Crawley GC, Edwards MP, Foster SJ, Girodeau JM, Kingston JF, McMillan RM. UK J Med Chem 1991; 34(7):2176.

98. Hoshino M, Sim JJ, Shimizu K, Nakayama H, Koya A. J Allergy Clin Immunol 1999; 103(6):1054.

99. Misra RN, Brown BR, Han WC, Harris DN, Hedberg A, Webb ML, Hall SE. J Med Chem 1991; 34(9):2882.

100. Beasly RCW, Featherstone RL, Church MK, Rafferty P, Varley JG, Harris A, Robinson C, Holgate ST. J Appl Physiol 1989; 66:1685.

101. Hubbard RC, Casolaro MA, Mitchell M, Sellers SE, Arabia F, Matthay MA, Crystal RG. Proc Natl Acad Sci 1989; 86:680.

102. FDC Reports, May 22, 1989.

Bonney RJ, Ashe B, Maycock A, Dellea P, Hand K, Osinga D, Fletcher D, Mumford R, Davies P, Frankenfield D, Nolan T, Schaeffer L, Hagman W, Finke F, Shah S, Dom C, Doherty J. J Cell Biochem 1989; 39:47.

Williams JC, Stein RL, Knee C, Egan J, Falcone R, Trainor D, Edwards P, Wolanin D, Wildonger R, Schwartz J, Heap B, Giles RE, Krell RD. Am Rev Respir Dis 1988; 137:206.

Iwasaw Y, Gillis CN, Aghajanian G. J Pharmacol Exp Ther 1973; 186:498. Pitt BR, Hammond GL, Gillis CN. J Appl Physiol 1982; 52:1545. Baron J, Bruke JP, Guengerich FP, Jakoby WB, Voigt JM. Toxicol Appl Pharmacol 1988; 93:493.

Forman HJ, Aldrich TK, Posner MA, Fisher AB. J Pharmacol Exp Ther 1982; 221:428.

Wilson AGE, Pickett RD, Eling TE, Anderson MW. Drug Metab Dispos 1979; 7:420.

Lullmann H, Rossen E, Seiler KU. J Pharm Pharmacol 1973; 25:239.

Minchin RF, Barber HE, Ilett KF. Drug Metab Dispos 1982; 10:356.

Fowler JS, Gallagher BM, MacGregor RR, Wolf AP. J Pharmacol Exp Ther 1976;

198:133.

Kostenbauder HB, Sloneker S. Prodrugs for pulmonary drug targeting. In: Byron PR, ed. Respiratory Drug Delivery. Boca Raton, FL: CRC Press, 1990:91-106. Kostenbauder HB. Extending duration of drug activity in the lung. In: Proceedings of the Second International Conference on Respiratory Drug Delivery (in press). Lofdahl CG, Svedmyr N. Acta Pharmacol Toxicol 1986; 5(suppl):229. Brittain RT, Dean CM, Jack D. Int Encycl Pharmacol Ther 1981; 104:613. Ullman A, Svednyr N. Thorax 1988; 423:674.

Suwa T, Kohno Y, Yoshida H, Morimoto S, Suga T. J Pharm Sci 1989; 79:783. Clissold SP, Heel RC. Drugs 1984; 28:485.

Edsbacker S. Studies on the Metabolic Fate and Human Pharmacokinetics of

Budenoside. Ph.D. dissertation, University of Lund, Sweden, 1986.

Andersson P, Lihne M, Thalen A, Ryrfeldt A. Xenobiotica 1987; 17:35.

Ryrfeldt A, Edsbacker S. Clin Pharmacol Ther 1984; 35:525.

Ryrfeldt A, Persson G, Nilsson E. Biochem Pharmacol 1989; 38:17.

Hussain AA, Truelove JE. U.S. Patent 3,868,461, 1975.

Shargel L, Dorrbecker SA. Drug Metab Dispos 1976; 4:72.

Olsson AT, Svensson L-A. Pharm Res 1984; 1:19.

Friedel HA, Brogden RN. Drugs 1988; 35:22.

Small D, Kostenbauder HB. Unpublished data, 1985.

Andersoon P. Acta Pharmacol Toxicol 1976; 39:225.

Ryrfeldt A, Bodin N-O. Xenobiotica 1975; 5:521.

Holstein-Rathlou N-H, Laursen LC, Madsen F, Svendsen UG, Grosspelius Y, Weeke B. Eur J Clin Pharmacol 1986; 30:7.

Sitar DS. Clinical pharmacokinetics of Bambuterol. Clin Pharmacokinet 1996; 31(4):246.

Svensson LA. Acta Pharm Suec 1987; 24:333. Svensson LA. Pharm Res 1985; 2:156.

Sharma R, Saxena D, Dwivedi AK, Misra A. Pharm Res 2001; 18:1405.

Zhou H, Lengsfeld C, Claffey DJ, Ruth JA, bertson B, Rondolph TW, Ng K,

Manning M. J Pharm Sci 2002; 91(6):1502.

Ranney DF. Biochem Pharmacol 1986; 35:1063.

Ranney DF. International Patent, WO 88/07365, 1988.

Krepela E, Vicar J, Zizkova L, Dazafirek E, Kolar Z, Lichnovsky V. Lung 1985; 163:33.

Catravas JD, White RE. J Appl Physiol 1981; 50:1161.

Ryan US, Ryan JW, Whitaker C, Chiu A. Tissue Cell 1976; 8:125.

Dent G, Giembycz MA, Rabe KF, Barnes PJ. Br J Pharmacol 1991; 103:1339. Staford JA, Feldman PL. Annu Rep Med Chem 1996; 34(8):71. Santing RE, Olymunder CG, Molen KV, Meurs H, Zaagsma J. Eur J Pharmacol 1995; 275:75.

Tanaka T, Yamamoto A, Amenomori A. European Patent Applications. EPO671389.

Stafford JA, Veal JM, Feldman PL, Valvano NL, Baer PG, Brackeen MF, Brawley ES, Cornolly KM, Domanico PL, Han B, Rose DA, Rutkowske RD, Sekut L, Strickland AB, Verghese MW. J Med Chem 1995; 38:4972. Takenag AK. Invasion Metastasis 1997; 16(2):97.

Crooks PA. Lung peptidases and their activities. In: Proceedings of the Second

International Conference on Respiratory Drug Delivery (in press).

Catravas JD, Lazo JS, Dobuler KJ, Mills LR, Gillis CN. Am Rev Respir Dis 1983;

128:740.

Ryan US. Endothelial cell activation response. In: Ryan US, ed. Pulmonary Endothelium in Health and Disease. New York: Marcel Dekker, 1987:3. Ryan JW. Assay of pulmonary endothelial surface enzymes in vivo. In: Ryan US, ed. Pulmonary Endothelium in Health and Disease. New York: Marcel Dekker, 1987:161.

Rigaudy R, Charcosset J-Y, Garbay-Jaureguiberry C, Jacquemin-Sablon A, Roques BP. Cancer Res 1989; 49:1836.

Shao J, Dettaven J, Laman D, Weissman DN, Ruyan K, Malanga C, Rojanasakul Y, Ma J. Drug Deliv 2001; 8(2):61.

Shao J, Dettaven J, Laman D, Weissman DN, Malanga C, Rojanasakul Y, Ma J. Drug Deliv 2001; 8(2):71.

Jones AL, Kellaway IW, Taylor G. J Pharm Pharmacol 1989; 41:92P. King GL, Johnson SM. Science 1985; 227:1583.

Sezaki H, Hashida M. CRC Crit Rev Ther Drug Carrier Syst 1984-1985; 1:1. Hashida M, Kato A, TakaBura Y, Sezaki H. Drug Metab Dispos 1984; 12. Tomlinson E. Site-specific drug deliver using particulate systems. In: Bunker G, Rhodes CT, eds. Modern Pharmaceutics. 40:673-693.

Miyamoto K, Shultz E, Heath T, Mitchell MD, Albertine KH, Staul NC. J Appl Physiol 1988; 64:1143.

Warner AE, Molilna RM, Brain JD. Am Rev Respir Dis 1987; 136:683.

164. Gillespie MN, Aziz SM, Pauly TH. Pulmonary intravascular macrophages: cellular targets of opportunity for inhaled drugs. In: Proceeds of the Second International Conference on Respiratory Drug Delivery (in press).

165. Brain JD, Warner AE, Molina RM, DeCamp MM. Am Rev Respir Dis 1988; 137:A147.

166. Illum L, Davis SS, Muller RH, Mak E, West P. Life Sci 1987; 40:367.

167. Illum L, Davis SS. FEPS Lett 1984; 107:79.

168. Kopecak J, Duncan R. Poly N-(2-hydroxypropyl) methacrylamide macromolecules as drug carrier systems. In: Ilium L, Davies SS, eds. Controlled Release of Drugs from Polymeric Particles and Macromolecules. Bristol, UK: Adam Hilger, 1988.

169. Kopecek J. Synthesis of tailor-made soluble polymeric drug carriers. In: Kim SW, Anderson J, eds. Recent Advances in Drug Delivery Systems. New York: Plenum Press, 1984:41.

170. Kojima T, Hashida M, Muranishi S, Sezaki H. J Pharm Pharmacol 1980; 32:30.

171. Fimm MV. CRC Crit Rev Ther Drug Carrier Syst 1988; 5:189.

172. Ryser HJP, Shen WC. Proc Natl Acad Sci USA 1978; 75:3867.

173. Chu BCF, Whiteley JM. Mol Pharmacol 1980; 17:382.

174. Robbins JC, Lam MH, Tripp CS, Bugianesi RL, Ponpipom MM, Shen TY. Proc Natl Acad Sci USA 1981; 78:7924.

175. Monsigny M, Roche A-C, Bailey P. Biochem Biophys Res Commun 1984; 121:579.

176. Kerr DJ, Hynds SA, Shepherd J, Packard CJ, Kaye SB. Biochem Pharmacol 1988; 37:3981.

177. Veale D, Kerr N, Gibson GJ, Harris AL. Cancer Res 1989; 49:1313.

178. Masui H, Kawamoto T, Sato JD, Wolf B, Sato G, Mendelsohn J. Cancer Res 1984; 44:1002.

179. Vollmar AM, Banker DE, Mendelsohn J, Herschman HR. J Cell Physiol 1987; 131:418.

180. Gu J-M, Robinson JR, Leung S-HS. CRC Crit Rev Ther Drug Carrier Syst 19881989; 5:21.

181. Bruck A, Abu-Dahab R, Borchard G, Schafer UF, Lehr CM. Drug Targeting 2001; 9(4):241.

182. Waldrep JC, Gilbert BE, Knight CM, Black MB, Scherer PW, Knight V, Eschenbacher W. Chest 1997; 111:316.

183. Terranova V, Rohrbach D, Martin GR. Cell 1980; 22:719.

184. Vlodavsky D. Gospodarowicz. Nature (London) 1980; 289:304.

185. Rennard SI, Gullino M, Martin JR, Katz SI. Lab Investig 1980; 42:336.

186. Lopes JD, dos Reis M, Brentani RR. Science 1985; 229:275.

187. Malinoff HL, Wicha MS. J Cell Biol 1983; 96:1475.

188. Newman SA, Frenz DA, Tomasek JJ, Rabuzzi DD. Science 1985; 228:885.

189. Brown PJ, Juliano RL. Science 1985; 228:1448.

190. Williams SK, Devenny JJ, Bitensky MM. Proc Natl Acad Sci USA 1981; 78:2393.

191. Fransson L-A. Eur J Biochem 1981; 120:251.

192. Shimada K, Gill PJ, Silbert JE, Douglas WH. J Clin Investig 1981; 68:995.

193. Ordonez NG, Batsakis JG. Arch Pathol Lab Med 1984; 108:129.

Holthofer H, Virtanen I, Kariniemi A-L, Hormia M, Linder E, Miettinen A. Lab Investig 1982; 47:60.

Miettinen M, Holthofer H, Lehto V-P, Miettinen A, Virtanen I. Am J Clin Pathol 1983; 79:32.

Pietra GG, Sampson P, Lanken PN, Hansen-Flaschen J, Fishman AP. Lab Investig 1983; 49:54.

Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MA. J Exp Med 1984; 160:618.

Anderson JH, Koivisto VA. Drugs Today 1998; 34:37. Owens D. Nat Res Drug Discov 2002; 1(17):529.

Steiner S, Pfutzner A, Wilson BR, Harzer O, Heinemann L, Rave K. Exp Clin Endocrinol Diabetes 2002.

Skyler JS, Cetalu WT, Kourides IA, Landschulz WH, Balagtas CC, Cheng SL,

Gelfand RA. Lancet 2001; 357(9253):331.

Mathe G, Tran BL, Bernard J. Compt Rend 1958; 246:1626.

Takacs L, Vazquez-Abad MD, Elliott EA. Annu Rep Med Chem 2001; 36(23):237.

Stephens S, Emtage S, Vetterlein O, Chaplin L, Bebbington C, Nesbitt A, Sopwith

M, Thwal DA, Novak C, Bodmer M. Immunology 1995; 85:668.

Pimm MV. CRC Crit Rev Ther Drug Carrier Syst 1988-1989; 5:189.

Chan YT, Evans GI, Ritson A, Watson J, Wraight P, Sikora K. Br J Cancer 1986;

54:761.

Milgrom H, Fick RB Jr., Su JQ, Reimann JD, Bush RK, Watrous ML, Metzger WJ.

N Engl J Med 1999; 341:1966.

Easthope S, Jarvis B. Drugs 2001; 61(2):253.

Colcher D, Esterban J, Carrasquillo JA, Sugarbaker P, Reynolds JC, Bryant G, Larson SM, Schlom J. Cancer Res 1987; 47:4218.

De Duve C, De Barsy T, Poole B, Trouet A, Tuckens P, Van Hoof F. Biochem Pharmacol 1975; 23:2495.

Pimm MV, Jones JA, Price MR, Middle JG, Embleton JM, Baldwin RW. Cancer Immunol Immunother 1982; 12:125.

Hurwitz E, Schechter B, Arnon R, Sela M. Int J Cancer 1979; 24:461. Tsukada Y, Ohkawa K, Hibi N. Cancer Res 1997; 47:4293. Garnett MC, Embleton MJ, Jacobs E, Baldwin RW. Int J Cancer 1983; 31:661. Tsukada Y, Kato Y, Takeda Y, Hara T, Hirai H. J Natl Cancer Inst 1984; 73:721. Corvalan JRF, Smith W, Gore VA, Brandon DR. Cancer Immunol Immunother 1987; 24:133.

Corvalan JRF, Smith W. Cancer Immunol Immunother 1987; 24:127. Corvalan JRF, Smith W, Gore VA, Brandon DR, Ryde PJ. Cancer Immunol Immunother 1997; 24:138.

Hnatowich DJ, Virzi F, Rusckowski M. J Nucl Med 1987; 28:1294. Andrew SM, Perkins AC, Pimm MV, Baldwin RW. Eur J Nucl Med 1988; 13:598. Buchegger F, Haskell CM, Schreyer M, Scazziga BR, Randin S, Carrel S, Mach I-P. J Exp Med 1983; 158:413.

Rowland GF, Simmonds RG, Gore VA, Marsden CH, Smith W. Cancer Immunol Immunother 1986; 21:183.

223. Brown PJ, Juliano RL. Science 1985; 228:1448.

224. Wick G, Muller PU, Timpl R. Clin Immunol Immunother 1982; 23:656.

225. Hirota N, Ueda M, Ozawa S, Abe O, Shimizu N. Cancer Res 1989; 49:7106.

226. Endo K, Kamma H, Ogata T. Cancer Res 1987; 47:5427.

227. Chan SYT, Evan GI, Ritson A, Watson J, Wraight P, Sikora K. Br J Cancer 1986; 54:761.

228. Zhu D, Cheng CF, Pauli BU. J Clin Investig 1992; 89:1718.

229. Elble RC, Widom J, Levine R, Goodwin A, Cheng HC, Pauli BU. J Biol Chem 1997; 272:27853.

231. Schroff RW. Cancer Res 1985; 45:879.

232. Birch JR, Lennox ES, eds. Monoclonal Antibodies. New York: Wiley-Liss, 1995.

233. Van Spriel AB, Van Ojik HH, Van De Winkel JGJ. Immunol Today 2000; 21:391.

234. Weibel ER, Gil J. Respir Physiol 1969; 4:42.

235. Rowlands DT, Daniele RP. N Engl J Med 1975; 293:26.

Diabetes 2

Diabetes 2

Diabetes is a disease that affects the way your body uses food. Normally, your body converts sugars, starches and other foods into a form of sugar called glucose. Your body uses glucose for fuel. The cells receive the glucose through the bloodstream. They then use insulin a hormone made by the pancreas to absorb the glucose, convert it into energy, and either use it or store it for later use. Learn more...

Get My Free Ebook


Post a comment